Project title: MINIMALLY INVASIVE MASTOPEXY

Company name : ORBIX MEDICAL LTD.

TECHNOLOGICAL FIELD
Medical devices

KEY WORDS
Minimally invasive
Mastopexy, Plastics Surgery, Breast Sagging, Breast Lifting,
Breast Augmentation

PROJECT SUMMARY
ORBIX MEDICAL LTD. (formerly Minimally Invasive Mastopexy (MIM))
developed an innovative technology and a kit that is intended to
support and lift soft tissues in different body parts which
require lifting and reshaping from aesthetic and other reasons.
This, by a minimally invasive approach which simplifies the
procedure, reduces recovery period and eliminates scars.
In the first stage, ORBIX is focusing on developing the Cup&Up
kit for solving the breast sagging (ptosis) problem. As women
age, the breasts may begin to sag or become ptotic. This process
is often accelerated by pregnancy and nursing. Mastopexy, or
breast lifting, may be performed to enhance the shape of the
breast and to obtain a more youthful appearance, improved
projection, and reduced ptosis. The Mastopexy procedure is
performed as a stand alone procedure or often as part of a breast
augmentation procedure. The Mastopexy procedure involves massive
interference with both internal and external breast tissues.
Unfortunately, the aesthetic improvement achieved comes at the
cost of noticeable scars and asymmetry. In addition, the
procedure, which is not suitable for the early stage of breast
sagging, is an expensive, long term recovery procedure, with
potential specific risks and complications and short term effect.
The target market for ORBIX Mastopexy procedure includes the
existing mastopexy market. Since the breast lifting kit reduces
risks and presents better aesthetic results, ORBIX expects to
replace the existing breast mastopexy procedure and also to give
a better solution for women afraid of the present mastopexy
procedure. Furthermore, ORBIX unique procedure and breast lifting
kit can be used in conjunction with breast augmentation surgery
(which is currently the most popular of all breast surgery
procedures) or breast reduction procedures, providing an
excellent solution for a large group of women who require breast
lift in addition to augmentation (augmentation-pexy), and/or as a
preventive measure against ptosis process and enhancing the
aesthetic effect. It is also the only solution for early stage of
breast sagging and the only corrective measure for women
suffering from Pseudo-ptosis, an undesirable, post-surgical
process usually observed in postpartum breast atrophy,
characterized by inferior pole ptosis with nipple at or above the
inframammary fold.

ENTREPRENEURS
Mr. Adi Cohen - Executive Chairman, MBA, B.A.
accounting,
Dr. Eyal Gur - Founder, Clinical internal consultant, M.D.,
Ph.D., Head Microsurgery Department, Sourasky Medical Center
Tel-Aviv, Israel.
Dr. Moshe Kon - Clinical Advisory Board, M.D.,
Ph.D., Head of the Department of Plastic, Reconstructive and
Handsurgery, UMC Utrecht
Mr. Adiel Shefaram - Product developer, a record of
success in the development of medical equipment.
Mr. Zvika Rubinstein - Director, CEO of Meytav
Technological Incubator

PROJECT STATUS
ORBIX Ltd. was established on September 2004. In August 2006
ORBIX renewed its operations as a Meytav Protfolio Company.
The Company is developing an innovative technology and a breast
lifting kit that is intended to revolutionize the field of
cosmetic breast surgery by replacing the breast lifting procedure
(mastopexy) and becoming an integral part of breast augmentation
and breast reduction procedures.

Patent application was submitted in Israel, United States,
Europe, Australia, Canada, Mexico, Brazil, Japan and China. The
patent application covers both the MIM technique and the
accompanying proprietary Cup&Up kit. The application was followed
by a PCT application and already entered into the National phase.

COOPERATION REQUIRED
MIM is seeking investment to accelerate product development. MIM
is also interesting in strategic partnerships with leading
plastic surgeons and/or distributors of medical and cosmetic
equipment with a worldwide distribution network and a
specialization in the American cosmetic surgery market.
---------------------------------------------------
TEL: 972-4-6818801 FAX: 972-4-6818806 EMAIL: adi@haargaz.co.il

Request for more information, about this project.

Note - you have to be registered in this server to request information. If you haven't done so yet, please:
Register in this server and your requests will be forwarded to the developer, who will contact you directly

List of projects that you already requested more information about